LogicBio’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

LogicBio is a biotechnology company that develops genetic medicines to treat rare pediatric diseases. Read more

Frederic Chereau's photo - President & CEO of LogicBio

President & CEO

Frederic Chereau

CEO Approval Rating

82/100

Founded:

2014

Status:

PublicNASDAQLOGC

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Sangamo is seen as one of LogicBio's top competitors. Sangamo was founded in Brisbane, California} in 1995. Sangamo is in the Biotechnology industry. Compared to LogicBio, Sangamo generates $107.6M more revenue.

bluebird bio is LogicBio's #2 competitor. bluebird bio was founded in 1992, and its headquarters is in Cambridge, Massachusetts. bluebird bio competes in the Biotechnology industry. bluebird bio has 1,126 more employees than LogicBio.

Recombinetics is LogicBio's #3 rival. Recombinetics is headquartered in Saint Paul, Minnesota, and was founded in 2008. Like LogicBio, Recombinetics also competes in the Biotechnology industry. Recombinetics generates 186% the revenue of LogicBio.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Ember Therapeutics a competitor of LogicBio?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$3.9M

LogicBio's revenue is the ranked 19th among it's top 10 competitors. The top 10 competitors average 178.4M. Over the last four quarters, LogicBio's revenue has decreased by 5.5%. Specifically, in Q2 2020's revenue was $ < 1M; in Q1 2020, it was $1M; in Q4 2019, it was $1M; in Q3 2019, LogicBio's revenue was $1M.

Acquisitions

No recent acquisitions found related to LogicBio

LogicBio Funding History

$4M$49M$129.5M$149.5M

Since LogicBio was founded in 2014, it has participated in 4 rounds of funding. In total LogicBio has raised $149.5M. LogicBio's last funding round was on Jul 2019 for a total of $20.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Jul 2019
$20M

Oxford Finance LLC

IPO
Oct 2018
$80.5M
-
Series B
Jun 2017
$45M
Equity
Jan 2016
$4M

Total Funding: $149.5M

Since LogicBio was founded in 2014, it has participated in 4 rounds of funding. In total LogicBio has raised $149.5M. LogicBio's last funding round was on Jul 2019 for a total of $20.0M

Investments

No recent investments found related to LogicBio

LogicBio News

August 10, 2020NewsOk

2Q Earnings Snapshot

LEXINGTON, Mass. (AP) _ LogicBio Therapeutics Inc.Read more on NewsOK.com... See more »
June 5, 2020BioSpace

LogicBio Therapeutics to Hold Virtual-Only Annual Meeting of Stockholders - June 05, 2020

LogicBio Therapeutics, Inc., a genome editing company focused on developing medicines to durably trea... See more »
May 28, 2020Zolmax News

LogicBio Therapeutics (NASDAQ:LOGC) & Aptose Biosciences (NASDAQ:APTO) Financial Review

LogicBio Therapeutics (NASDAQ:LOGC) and Aptose Biosciences (NASDAQ:APTO) are both small-cap medical c... See more »
May 18, 2020MarketScreener

ROSEN, NATIONAL TRIAL LAWYERS, Reminds LogicBio Investors of Important Deadline in Securities Class Action - LOGC

(marketscreener.com) NEW YORK, May 18, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights ... See more »
May 18, 2020Zolmax News

Equities Analysts Offer Predictions for LogicBio Therapeutics Inc's Q2 2020 Earnings (NASDAQ:LOGC)

LogicBio Therapeutics Inc (NASDAQ:LOGC) - Jefferies Financial Group raised their Q2 2020 earnings per... See more »

LogicBio Press Releases

April 15, 2020GlobalNewswire

ROSEN, A RANKED AND LEADING FIRM, Reminds LogicBio Therapeutics, Inc. Investors of the Important May 18th Deadline in Securities Class Action - LOGC

NEW YORK, April 15, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, remin... See more »
April 12, 2020centralcharts

ROSEN, A TOP LAW FIRM, Reminds LogicBio Therapeutics, Inc. Investors With Large Losses of the May 18th Deadline in Class Action Seeking Recovery of Investor Losses - LOGC

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of LogicBio T... See more »
February 10, 2020centralcharts

LogicBio Therapeutics Provides Update on FDA Review of Investigational New Drug Application for LB-001 for Methylmalonic Acidemia

CAMBRIDGE, Mass., Feb. 10, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a geno... See more »
August 13, 2019GlobeNewswire

LogicBio Reports Second Quarter 2019 Financial Results and Provides Business Updates

CAMBRIDGE, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicB... See more »
July 16, 2019GlobeNewswire

LogicBio Therapeutics Receives Rare Pediatric Disease Designation for LB-001 for the Treatment of Methylmalonic Acidemia

CAMBRIDGE, Mass., July 16, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a geno... See more »
May 14, 2019GlobeNewswire

LogicBio Reports First Quarter 2019 Financial Results and Provides Business Updates

CAMBRIDGE, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBi... See more »
April 1, 2019GlobeNewswire

LogicBio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Updates

CAMBRIDGE, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (Logic... See more »

Social Statistics

Headquarters

-

Cambridge, Massachusetts-

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

LogicBio is a biotechnology company that develops genetic medicines to treat rare pediatric diseases. LogicBio was founded in 2014. LogicBio's headquarters is located in Cambridge, Massachusetts, USA -. It has raised 149.5M in 4 rounds. The latest rou...

CEO

LogicBio's President & CEO, Frederic Chereau, currently has an approval rating of 82%. LogicBio's primary competitors are Sangamo, bluebird bio & Recombinetics.

Website

logicbio.com

Frequently Asked Questions about LogicBio

  1. When was LogicBio founded?

    LogicBio was founded in 2014
  2. Who is LogicBio's CEO?

    LogicBio's CEO is Frederic Chereau
  3. How much revenue does LogicBio generate?

    LogicBio generates $3.9M in revenue
  4. How much funding does LogicBio have?

    LogicBio has historically raised $149.5M in funding
  1. Where is LogicBio's headquarters?

    LogicBio's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does LogicBio have?

    LogicBio has 41 employees
  3. What sector does LogicBio operate in?

    LogicBio is in Biotechnology
  4. Who are LogicBio's competitors?

    LogicBio's top competitors are Sangamo, bluebird bio, Recombinetics